The purpose of this study was to investigate the spectrum of current treatment protocols for managing newly diagnosed chordoma of the mobile spine and sacrum.
A survey on the treatment of spinal chordoma was distributed electronically to members of the AOSpine Knowledge Forum Tumor, including neurosurgeons, orthopedic surgeons, and radiation oncologists from North America, South America, Europe, Asia, and Australia. Survey participants were pre-identified clinicians from centers with expertise in the treatment of spinal tumors. The suvey responses were analyzed using descriptive statistics.
Thirty-nine of 43 (91%) participants completed the survey. Most (80%) indicated that they favor en bloc resection without preoperative neoadjuvant radiation therapy (RT) when en bloc resection is feasible with acceptable morbidity. The main area of disagreement was with the role of postoperative RT, where 41% preferred giving RT only if positive margins were achieved and 38% preferred giving RT irrespective of margin status. When en bloc resection would result in significant morbidity, 33% preferred planned intralesional resection followed by RT, and 33% preferred giving neoadjuvant RT prior to surgery. In total, 8 treatment protocols were identified: 3 in which en bloc resection is feasible with acceptable morbidity and 5 in which en bloc resection would result in significant morbidity.
The results confirm that there is treatment variability across centers worldwide for managing newly diagnosed chordoma of the mobile spine and sacrum. This information will be used to design an international prospective cohort study to determine the most appropriate treatment strategy for patients with spinal chordoma.
ABBREVIATIONSHRQOL = health-related quality of life; RT = radiation therapy.
Correspondence Nicolas Dea: Vancouver General Hospital and The University of British Columbia, Vancouver, BC, Canada. email@example.com.
INCLUDE WHEN CITING Published online October 19, 2018; DOI: 10.3171/2018.6.SPINE18362.
Disclosures Dr. Dea reports consultant relationships with Medtronic, Baxter, and Stryker and direct stock ownership in Medtronic. Dr. Fisher reports consultant relationships with Medtronic and NuVasive as well as receipt of royalties from Medtronic. Dr. Rhines reports an educational relationship with Stryker. Dr. Gokaslan reports direct stock ownership in Spinal Kinetics. Dr. Sahgal reports the following financial relationships: educational seminars with Elekta AB, Accuray Inc, and Varian Medical Systems; a research grant from Elekta AB; and travel accommodations/expenses from Elekta and Varian. Dr. Sahgal also reports belonging to the Elekta MR Linac Research Consortium. Dr. Laufer reports consultant relationships with Globus, Medtronic, DePuy/Synthes, Spinewave, and Brainlab. Ms. Germscheid reports an employee relationship with AOSpine International.
DeLaneyTFLiebschNJPedlowFXAdamsJWeymanEAYeapBY: Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol110:115–1222014
IndelicatoDJRotondoRLBegosh-MayneDScarboroughMTGibbsCPMorrisCG: A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine. Int J Radiat Oncol Biol Phys95:297–3032016
KabolizadehPChenYLLiebschNHornicekFJSchwabJHChoyE: Updated outcome and analysis of tumor response in mobile spine and sacral chordoma treated with definitive high-dose photon/proton radiation therapy. Int J Radiat Oncol Biol Phys97:254–2622017
MolinaCAAmesCPChouDRhinesLDHsiehPCZadnikPL: Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience. J Neurosurg Spine21:348–3562014
ParkLDelaneyTFLiebschNJHornicekFJGoldbergSMankinH: Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys65:1514–15212006
PennicookeBLauferISahgalAVargaPPGokaslanZLBilskyMH: Safety and local control of radiation therapy for chordoma of the spine and sacrum: a systematic review. Spine (Phila Pa 1976)41(Suppl 20):S186–S1922016
ReynoldsJJKhundkarRBorianiSWilliamsRRhinesLDKawaharaN: Soft tissue and bone defect management in total sacrectomy for primary sacral tumors: a systematic review with expert recommendations. Spine (Phila Pa 1976)41(Suppl20):S199–S2042016
RotondoRLFolkertWLiebschNJChenYLEPedlowFXSchwabJH: High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine23:788–7972015
WeiFLiuZLiuXJiangLDangGPassiasPG: An approach to primary tumors of the upper cervical spine with spondylectomy using a combined approach: our experience with 19 cases. Spine (Phila Pa 1976)43:81–882018